• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    CytomX Therapeutics, Inc. - Common Stock (NQ: CTMX )

    1.070 UNCHANGED
    Streaming Delayed Price Updated: 1:00 PM EST, Dec 24, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 26
    Open 1.070
    Bid (Size) 1.060 (50)
    Ask (Size) 1.080 (45)
    Prev. Close 1.070
    Today's Range 1.070 - 1.070
    52wk Range 0.8330 - 5.850
    Shares Outstanding 66,767,779
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    12 Health Care Stocks Moving In Friday's Pre-Market Session
    Via Benzinga
    CTMX Stock Earnings: CytomX Therapeutics Beats EPS, Beats Revenue for Q2 2024
    CTMX stock results show that CytomX Therapeutics beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024. 
    Via InvestorPlace

    Performance

    YTD
    -36.69%
    -36.69%
    1 Month
    +11.42%
    +11.42%
    3 Month
    -8.55%
    -8.55%
    6 Month
    -11.57%
    -11.57%
    1 Year
    -27.70%
    -27.70%

    More News

    Read More
    (CTMX) - Analyzing CytomX Therapeutics's Short Interest
    Via Benzinga
    Buy Alert: 3 Penny Stocks That Will Explode in 2024
    Via InvestorPlace
    No Memes, Ma’am! Try a Sensible Biotech Bet With CytomX Therapeutics Stock.
    Via InvestorPlace
    Analysts' Varied Perspectives On CytomX's CX-904 Cancer Study: Safety Profile But Caution in Pancreatic Cancer
    Via Benzinga
    Gold Moves Higher; Roblox Issues Weak Outlook
    Via Benzinga
    Why Duolingo Shares Are Trading Lower By Around 18%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
    Via Benzinga
    SOUN Stock Alert: SoundHound AI Announces New Partnership With Perplexity
    Via InvestorPlace
    Topics Artificial Intelligence
    Exposures Artificial Intelligence
    Dear NVDA Stock Fans, Mark Your Calendars for June 2
    Via InvestorPlace
    12 Health Care Stocks Moving In Thursday's Intraday Session
    Via Benzinga
    Dow Jumps Over 150 Points; US Foods Posts Upbeat Earnings
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    Why Is CytomX (CTMX) Stock Down 43% Today?
    Via InvestorPlace
    Why AppLovin Shares Are Trading Higher By 15%; Here Are 20 Stocks Moving Premarket
    Via Benzinga
    12 Health Care Stocks Moving In Thursday's Pre-Market Session
    Via Benzinga
    Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
    Via InvestorPlace
    CTMX Stock Earnings: CytomX Therapeutics Beats EPS, Beats Revenue for Q1 2024
    Via InvestorPlace
    12 Health Care Stocks Moving In Wednesday's After-Market Session
    Via Benzinga
    Breaking on The Street Stocks To Watch Now! CTMX, PRSO, IMCC, KAVL, VTAK
    Via AB Newswire
    Etsy Reports Downbeat Earnings, Joins Fastly, DoorDash And Other Big Stocks Moving Lower In Thursday's Pre-Market Session
    Via Benzinga
    12 Health Care Stocks Moving In Thursday's Pre-Market Session
    Via Benzinga
    Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
    Via InvestorPlace
    Why Aspen Aerogels Shares Are Trading Higher By 26%; Here Are 20 Stocks Moving Premarket
    Via Benzinga
    Dow Jumps 200 Points Following Fed Decision; Pfizer Earnings Top Estimates
    Via Benzinga
    Topics Economy Stocks
    Exposures Interest Rates US Equities
    Why AMD Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
    Via Benzinga
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.